Vident Advisory LLC Invests $55,000 in Nano-X Imaging Ltd. $NNOX

Vident Advisory LLC acquired a new stake in shares of Nano-X Imaging Ltd. (NASDAQ:NNOX) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 10,985 shares of the company’s stock, valued at approximately $55,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. PFG Advisors increased its stake in Nano-X Imaging by 25.3% during the first quarter. PFG Advisors now owns 12,782 shares of the company’s stock worth $64,000 after acquiring an additional 2,582 shares during the last quarter. OneDigital Investment Advisors LLC increased its stake in Nano-X Imaging by 16.5% during the first quarter. OneDigital Investment Advisors LLC now owns 32,271 shares of the company’s stock worth $161,000 after acquiring an additional 4,570 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in Nano-X Imaging by 26.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 21,990 shares of the company’s stock worth $159,000 after acquiring an additional 4,658 shares during the last quarter. Rhumbline Advisers boosted its position in shares of Nano-X Imaging by 6.6% in the first quarter. Rhumbline Advisers now owns 76,728 shares of the company’s stock worth $383,000 after buying an additional 4,756 shares during the period. Finally, ProShare Advisors LLC boosted its position in shares of Nano-X Imaging by 50.9% in the fourth quarter. ProShare Advisors LLC now owns 15,464 shares of the company’s stock worth $111,000 after buying an additional 5,216 shares during the period. Institutional investors and hedge funds own 21.49% of the company’s stock.

Nano-X Imaging Trading Up 5.0%

Shares of NASDAQ NNOX opened at $3.97 on Friday. The company has a market cap of $229.39 million, a price-to-earnings ratio of -4.41 and a beta of 1.94. Nano-X Imaging Ltd. has a 12-month low of $3.63 and a 12-month high of $11.00. The stock’s 50 day simple moving average is $4.55 and its 200 day simple moving average is $5.03.

Nano-X Imaging (NASDAQ:NNOX) last announced its earnings results on Tuesday, August 12th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.08). The business had revenue of $3.04 million for the quarter, compared to the consensus estimate of $3.20 million. Nano-X Imaging had a negative net margin of 468.29% and a negative return on equity of 32.09%. As a group, equities analysts forecast that Nano-X Imaging Ltd. will post -0.92 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on NNOX. D. Boral Capital decreased their price target on Nano-X Imaging from $10.00 to $8.00 and set a “buy” rating for the company in a report on Wednesday, August 13th. Alliance Global Partners upgraded Nano-X Imaging to a “strong-buy” rating in a report on Monday, August 11th. Finally, LADENBURG THALM/SH SH upgraded Nano-X Imaging to a “strong-buy” rating in a report on Monday, July 14th. Two analysts have rated the stock with a Strong Buy rating and two have assigned a Buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Strong Buy” and a consensus target price of $8.50.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.